Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
HIV Medicine|May 20, 2008
Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot studyJ M Llibre, A Bonjoch, J Iribarren, et al.
HIV Medicine|February 26, 2015
Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialJ D Baxter, D Dunn, E White, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2007
De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis CR Martín-Santos, C Díez-Quevedo, P Castellví, et al.
HIV Medicine|January 29, 2019
Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohortJ M Llibre, A Montoliu, J M Miró, et al.
HIV Medicine|January 29, 2019
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfectionJ J Malin, C Boesecke, C Schwarze-Zander, et al.
HIV Clinical Trials|July 13, 2004
Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy)A Casado, X Badia, E Consiglio, et al.
Actas Dermo-Sifiliograficas|December 3, 2014
Drug eruptions induced by telaprevir in patients with chronic hepatitis C virus genotype 1 infection: a prospective studyM Toro Montecinos, J M Carrascosa Carrillo, M Vilavella Rius, et al.
HIV Medicine|November 28, 2015
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapyA Winston, W Stöhr, A Antinori, et al.
Open Forum Infectious Diseases|March 3, 2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)D Podzamczer, R Micán, J Tiraboschi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 28, 2023
Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel diseaseA Martin-Cardona, D Horta, P Florez-Diez, et al.
Pageof 4